The project KinCellS, supported by the Auvergne Rhone Alpes region, as part of the call for R&D booster projects, was launched on September 9th, 2020, with the consortium members : Nanobiose, project leader, EVEON and the SyMMES laboratory.

Article OnDrugDelivery about the results of work carried out in joint efforts by EVEON and LMGP in the field of protein adsorption and aggregation, and how the results of this work have led to improvements in the design of EVEON’s proprietary micropump.

EVEON is proud to be part, again in 2020, of Team Excellence - bpifrance.

EVEON celebrated its 10th anniversary and is ranked by Forbes as the 3rd most inventive French company in the medical technologies category.

EVEON is proud to be in Forbes' ranking as one of the best French inventors, thanks to its strong portfolio of patents, to its development, to R&D investment.

Supported by the European Union, the project ISIS aims to develop and industrialize a connected and secure medical device for automated drug reconstitution.

The presentation of the DIPSA project, needle-free piezoelectric injection device, to the Auvergne Rhone Alpes region, as part of the call for R&D booster projects, received a favourable opinion in March 2019. The project was launched on Tuesday, April 15, 2019, at Cedrat Technologies (CTEC), project coordinator, with EVEON, as industrial partner, and the Grenoble Rheology and Processes Laboratory (LRP). 

EVEON, as part of a partnership with a pharmaceutical laboratory, has delivered, on schedule, the first functional prototypes based on the innovative medical device Intuity® Ject.

EVEON is a partner of ROBOLAB project, selected by the 25th call for projects by the FUI inter-ministerial fund. Carried by PMB, a subsidiary of the ALCEN group, CEA’s imaging centre, SHFJ, is also taking part in the project.

EVEON is announcing that it has forged a partnership with a pharmaceutical laboratory for a development based on the innovative Intuity® Ject medical device, recipient of a 2017 Pharmapack Award.